In prostate cancer, high IL-7 expression correlates with poor prognosis because IL-7R activation promotes invasion and migration via the AKT/NF-κB pathway and matrix metalloproteinase (MMP) regulation [51,52]. Here, AKT1 is linked to prostate carcinoma.